FIELD: medicine.
SUBSTANCE: invention refers to medicine and aims at treating the patients with lichen acuminatus in an oral mucosa. The method involves using a conventional integrated therapy: vitamins, antihistaminic agents and anxiolytics. With underlying the therapy, from the first therapeutic day, the immunomodulator 12.5% neovir 250 mg is introduced intramuscularly once a day every 48 hours between the single doses in the amount of 5-10 injections per one course.
EFFECT: method enables ensuring the stable positive effect in the patients suffering lichen acuminatus in the oral mucosa remitted up to 1,5 years, normalising the cytokine profile values both at the systemic, and at the local levels.
4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF EROSIVE AND ULCERENT FORM OF LICHEN FLAT OF MOUTH MUCOSA | 2022 |
|
RU2802551C1 |
| METHOD FOR PREDICTION OF MISCARRIAGE IN FEMALES WITH HYPOTHALAMIC SYNDROME | 2019 |
|
RU2712453C1 |
| METHOD FOR INFERTILITY PREDICTION IN FEMALES WITH HYPOTHALAMIC SYNDROME | 2019 |
|
RU2740013C2 |
| METHOD OF CLINICAL OUTCOME FORECAST OF ACUTE VIRAL HEPATITIS B | 2007 |
|
RU2325656C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF ADJUVANT INTERFERON THERAPY OF SKIN MELANOMA | 2019 |
|
RU2722403C1 |
| METHOD OF ALLERGEN-SPECIFIC IMMUNOTHERAPY EFFICIENCY EVALUATION APPLIED FOR CHILDREN SUFFERING FROM BRONCHIAL ASTHMA | 2007 |
|
RU2327993C1 |
| METHOD FOR PREDICTING THE LETHAL OUTCOME IN PATIENTS WITH SEVERE CoVID-19 | 2021 |
|
RU2780748C1 |
| METHOD OF TREATING LICHEN ACUMINATUS OF ORAL MUCOSA | 2010 |
|
RU2449806C1 |
| METHOD OF TREATING PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE | 2012 |
|
RU2495687C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF GASTROESOPHAGEAL REFLUX DISEASE | 2012 |
|
RU2530634C2 |
